A detailed history of Achmea Investment Management B.V. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Achmea Investment Management B.V. holds 192,103 shares of MRK stock, worth $18.8 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
192,103
Previous 177,060 8.5%
Holding current value
$18.8 Million
Previous $21.9 Million 0.48%
% of portfolio
0.36%
Previous 0.39%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$111.15 - $128.97 $1.67 Million - $1.94 Million
15,043 Added 8.5%
192,103 $21.8 Million
Q2 2024

Aug 08, 2024

BUY
$123.8 - $132.96 $1.52 Million - $1.63 Million
12,249 Added 7.43%
177,060 $21.9 Million
Q1 2024

May 08, 2024

SELL
$113.24 - $131.95 $23 Million - $26.8 Million
-203,288 Reduced 55.23%
164,811 $21.7 Million
Q4 2023

Feb 12, 2024

SELL
$100.18 - $109.02 $4.81 Million - $5.23 Million
-47,998 Reduced 11.54%
368,099 $40.1 Million
Q3 2023

Nov 06, 2023

BUY
$102.95 - $114.33 $185,721 - $206,251
1,804 Added 0.44%
416,097 $42.8 Million
Q2 2023

Jul 24, 2023

BUY
$108.61 - $118.38 $6.59 Million - $7.18 Million
60,681 Added 17.16%
414,293 $47.8 Million
Q1 2023

May 04, 2023

BUY
$102.94 - $114.86 $2.04 Million - $2.28 Million
19,857 Added 5.95%
353,612 $37.6 Million
Q4 2022

Feb 09, 2023

BUY
$87.44 - $112.11 $37,599 - $48,207
430 Added 0.13%
333,755 $34.7 Million
Q3 2022

Oct 27, 2022

BUY
$84.53 - $94.96 $4.94 Million - $5.55 Million
58,447 Added 21.26%
333,325 $28.7 Million
Q2 2022

Aug 10, 2022

BUY
$83.49 - $94.64 $2.48 Million - $2.81 Million
29,730 Added 12.13%
274,878 $25.1 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $18 Million - $20.2 Million
245,148 New
245,148 $20.1 Million
Q4 2021

Feb 10, 2022

SELL
$72.28 - $90.54 $17.2 Million - $21.5 Million
-237,443 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $1.79 Million - $1.97 Million
-24,984 Reduced 9.52%
237,443 $17.8 Million
Q2 2021

Aug 06, 2021

SELL
$70.31 - $77.77 $4.65 Million - $5.14 Million
-66,119 Reduced 20.12%
262,427 $20.4 Million
Q1 2021

May 11, 2021

BUY
$68.86 - $81.11 $959,082 - $1.13 Million
13,928 Added 4.43%
328,546 $25.3 Million
Q4 2020

Feb 22, 2021

BUY
$71.77 - $79.65 $2.25 Million - $2.49 Million
31,309 Added 11.05%
314,618 $25.7 Million
Q3 2020

Nov 02, 2020

SELL
$73.18 - $82.95 $54.2 Million - $61.5 Million
-740,987 Reduced 72.34%
283,309 $23.5 Million
Q2 2020

Aug 12, 2020

SELL
$70.42 - $80.13 $12 Million - $13.6 Million
-169,785 Reduced 14.22%
1,024,296 $79.2 Million
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $49.7 Million - $68.9 Million
784,901 Added 191.82%
1,194,081 $91.9 Million
Q4 2019

Feb 10, 2020

SELL
$77.58 - $87.54 $193,174 - $217,974
-2,490 Reduced 0.6%
409,180 $37.2 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $1.11 Million - $1.21 Million
-14,557 Reduced 3.42%
411,670 $34.7 Million
Q2 2019

Aug 06, 2019

BUY
$69.84 - $81.59 $240,948 - $281,485
3,450 Added 0.82%
426,227 $35.7 Million
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $361,816 - $412,672
5,200 Added 1.25%
422,777 $35.2 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $9.9 Million - $11.5 Million
151,799 Added 57.11%
417,577 $31.9 Million
Q3 2018

Nov 06, 2018

SELL
$57.69 - $67.84 $1.38 Million - $1.62 Million
-23,866 Reduced 8.24%
265,778 $18.9 Million
Q2 2018

Jul 27, 2018

SELL
$50.83 - $59.72 $878,291 - $1.03 Million
-17,279 Reduced 5.63%
289,644 $17.6 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $8.16 Million - $9.48 Million
-160,041 Reduced 34.27%
306,923 $16.7 Million
Q4 2017

Feb 12, 2018

BUY
$51.62 - $61.64 $8.05 Million - $9.61 Million
155,853 Added 50.1%
466,964 $26.3 Million
Q3 2017

Nov 09, 2017

SELL
$58.67 - $63.13 $1.38 Million - $1.49 Million
-23,566 Reduced 7.04%
311,111 $19.9 Million
Q2 2017

Aug 29, 2017

BUY
N/A
334,677
334,677 $21.4 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Achmea Investment Management B.V. Portfolio

Follow Achmea Investment Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.